Everything below concerns peptide acylation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-17. Numbers and descriptions here follow the published literature rather than marketing material.
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
| Property | Value | Notes |
|---|---|---|
| 储存温度 | 2 至 8 摄氏度 | 固体粉末，避光密封 |
| 外观 | 白色至类白色冻干粉 | 溶解后为澄清至微乳光 |
| 溶解性 | 易溶于水性缓冲液 | 避免剧烈振荡 |
| 常规纯度方法 | 反相高效液相色谱 | 紫外或质谱检测 |
| 定量方法 | 液相色谱串联质谱 | 配合固相萃取前处理 |
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
== Science and medicine == Pathologic complete response (pCR), in neoadjuvant therapy Polymerase chain reaction COVID-19 testing, often performed using the polymerase chain reaction method Phosphocreatine, a phosphorylated creatine molecule Principal component regression, a statistical technique Protein/creatinine ratio, in urine
Another major effort against the Huks was Operation "Knockout" of the Panay Task Force (composed of the 15th BCT, some elements of the 9th BCT and the PC commands of Iloilo, Capiz, and Antique) under the command of Colonel Alfredo M. Santos. The Operation conducted a surprise attack on Guillermo Capadocia, commander of the Huk Regional Command in the Visayas, erstwhile Secretary General and one of the founders of the PKP. Santos' masterstroke was the enlistment of Pedro Valentin, a local mountain leader who knew the people and the terrain like the back of his hand. Capadocia died on Panay, of battle wounds, on September 20, 1952. In 1954, Lieutenant Colonel Laureño Maraña, the former head of Force X of the 16th PC Company, assumed command of the 7th BCT, which had become one of the most mobile striking forces of the Philippine ground forces against the Huks, from Valeriano who was now a colonel. Force X employed psychological warfare through combat intelligence and infiltration that relied on secrecy in planning, training, and execution of attack. The lessons learned from Force X and Nenita were combined in the 7th BCT.
Mated females then seek a suitable place to begin a colony. There, they break off their wings using their tibial spurs and begin to lay and care for eggs. The females can selectively fertilise future eggs with the sperm stored to produce diploid workers or lay unfertilized haploid eggs to produce drones. The first workers to hatch, known as nanitics, are weaker and smaller than later workers but they begin to serve the colony immediately. They enlarge the nest, forage for food, and care for the other eggs. Species that have multiple queens may have a queen leaving the nest along with some workers to found a colony at a new site, a process akin to swarming in honeybees.
== Implications in health and industry == Quorum sensing bacteria within the human microbiome are responsible for many diseases including sinusitis, otitis media, pneumonia, bacteraemia, osteomyelitis, septic arthritis, and meningitis. In the United States alone there is a death toll of >22,000 a year tracing back to this pathogen. S. pneumoniae uses the competence stimulating peptide and quorum sensing to initiate its attack, establish an infection, and develop antibiotic resistance genes. Overall, competence stimulating peptide allows S. pneumoniae to initiate a more pervading attack on the human host. Currently in health and industry, studies center on explaining and intercepting the competence region within the S. pneumoniae. The goal is to limit cell–cell communication with the hopes of attenuating S. pneumoniae infectivity. Inhibiting the competence stimulating peptide shows potential as a way to combat pneumococcal infections.
Sources: en.wikipedia.org
Penicillium expansum is a psychrophilic blue mold that is common throughout the world in soil. It causes Blue Mold of apples, one of the most prevalent and economically damaging post-harvest diseases of apples. Though primarily known as a disease of apples, this plant pathogen can infect a wide range of hosts, including pears, strawberries, tomatoes, corn, and rice. Penicillium expansum produces the carcinogenic metabolite patulin, a neurotoxin that is harmful when consumed. Patulin is produced by the fungus as a virulence factor as it infects the host. Patulin levels in foods are regulated by the governments of many developed countries. Patulin is a particular health concern for young children, who are often heavy consumers of apple products. The fungus can also produce the mycotoxin citrinin.
ectopic Occurring or developing in an abnormal place or position or in an unusual form or manner; displaced, malpositioned, or produced in an unnatural context. For example, ectopic expression refers to the expression of a particular gene product in a cell or tissue where it is not normally expressed. Contrast entopic.
Solutions of hypochlorites can be produced in-situ by electrolysis of an aqueous sodium chloride solution in both batch and flow processes. The composition of the resulting solution depends on the pH at the anode. In acid conditions the solution produced will have a high hypochlorous acid concentration, but will also contain dissolved gaseous chlorine, which can be corrosive; at a neutral pH the solution will be around 75% hypochlorous acid and 25% hypochlorite. Some of the chlorine gas produced will dissolve forming hypochlorite ions. Hypochlorites are also produced by the disproportionation of chlorine gas in alkaline solutions.
=== Hacktivism === Politically motivated hacktivism involves the subversive use of computers and computer networks to promote an agenda, and can potentially extend to attacks, theft and virtual sabotage that could be seen as cyberwarfare – or mistaken for it. Hacktivists use their knowledge and software tools to gain unauthorized access to computer systems they seek to manipulate or damage not for material gain or to cause widespread destruction, but to draw attention to their cause through well-publicized disruptions of select targets. Anonymous and other hacktivist groups are often portrayed in the media as cyber-terrorists, wreaking havoc by hacking websites, posting sensitive information about their victims, and threatening further attacks if their demands are not met. However, hacktivism is more than that. Actors are politically motivated to change the world, through the use of fundamentalism. Groups like Anonymous, however, have divided opinion with their anarchic methods.
=== Ka–Ke === Henrik Kacser FRSE (1918–1995). British geneticist and biochemist at Edinburgh, founder of metabolic control analysis. Emil T. Kaiser (1938–1988). Hungarian-born American protein chemist at the University of Chicago, known for his work on enzyme modification. Member Natl. Acad. Sci. USA. Herman Kalckar (1908–1991). Danish biochemist at the New York Public Health Research Institute, who worked on cellular respiration, nucleotide metabolism and galactose metabolism. Member Natl. Acad. Sci. USA Nathan O. Kaplan (1917–1986) Enzymologist at UC San Diego, founding editor of Methods in Enzymology. Member Natl. Acad. Sci. USA Sir Bernard Katz FRS (1911–2003). German-British neuroscientist and biophysicist at University College London. Nobel Prize in Physiology or Medicine (1970) for work on nerve biochemistry and the pineal gland. Stuart Alan Kauffman (b. 1939). American theoretical biologist, expert on complex systems, now at the University of Pennsylvania. Fellow of the Royal Society of Canada. Douglas Kell (b. 1953). British biochemist at the University of Manchester, known for research on functional genomics, metabolomics and the yeast genome. John Kendrew FRS (1917–1997). British x-ray crystallographer at the European Molecular Biology Laboratory, Heidelberg, known for determining the crystal structure of myoglobin. Nobel Prize in Chemistry (1962). Sir Ernest Kennaway FRS (1881–1958), British pathologist at the Institute of Cancer Research, London, who carried out early work on carcinogenic effects of hydrocarbons. Eugene P.
Sources: en.wikipedia.org
建议在低温、避光、干燥环境中密封保存，常见条件为 2 至 8 摄氏度，长期存放可置于更低温度。应避免反复冻融，并尽量减少容器开启次数。
溶解后的稳定时间通常短于固体形态，受浓度、缓冲液和容器材质影响。冷藏条件下一般只能维持较短时间，具体期限应通过实际稳定性实验确认。
反相高效液相色谱用于纯度与含量测定，液相色谱串联质谱用于生物基质中的定量，体积排阻色谱用于检测聚集体。多种方法结合才能较完整地表征样品。
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.